Deciphera Pharmaceuticals, Inc.
(NASDAQ GS: DCPH)
Rigrodsky Law, P.A. is investigating Deciphera Pharmaceuticals, Inc. (“Deciphera”) regarding possible breaches of fiduciary duties and other violations of law related to Deciphera’s agreement to be acquired by ONO Pharmaceutical Co., Ltd. Under the terms of the agreement, Deciphera shareholders will receive $25.60 per share in cash.